Webinars

Friday, February 7, 2025 | 12pm CST

Perinatal Opioid Use Disorder Series #1

Objectives:

• Describe the clinical, ethical, and legal intersection when caring for pregnant and postpartum people with substance use disorders.
• Outline strength-based strategies to promote family unification.
• Identify local and national community partners who can help you holistically support pregnant and postpartum patients in their recovery.

Wednesday, February 12, 2025 | 12pm CST

Perinatal Mental Health Series #1

Objectives:

• Identify mechanism of action of zuranolone.  
• Describe how zuranolone may fit into the arsenal with other treatments for postpartum depression.  
• Identify barriers of use of zuranolone.  

Wednesday, May 14, 2025 | 12pm CST

Perinatal Mental Health Series #2

Objectives:

• Define the relationship between mental health and substance use disorders in the perinatal patient.  
• Identify the epidemiology of mental health and substance use disorders in the perinatal patient.  
• Describe strategies for management of co-occurring mental health and substance use disorders in the perinatal patient.  

Registration

Friday, May 16, 2025 | 12pm CST

Perinatal Opioid Use Disorder Series #2

Objectives:

• Identify the clinical presentation of NOWS
• Contrast diagnostic criteria for a diagnosis of NAS vs NOWS
• Distinguish how management of NOWS impacts outcomes

Registration

Wednesday, September 10, 2025 | 12pm CST

Perinatal Mental Health Series #3

Objectives:

• Describe the criteria for attention deficit hyperactivity disorder (ADHD). 
• Differentiate between “normal” attentional symptoms during the perinatal period versus a perinatal patient with ADHD. 
• Identify risks to the fetus and newborn of stimulant (e.g. amphetamine, methylphenidate, and lisdexamfetamine) exposure in utero. 

Registration

Friday, August 22, 2025 | 12pm CST

Perinatal Opioid Use Disorder Series #3

Objectives:

• Understand the risks to the patient, the pregnancy and the infant of perinatal substance use
• Identify harm reduction strategies for perinatal patients who use substances
• Describe harm reduction resources and organizations available for healthcare providers caring for perinatal patients 

Registration

Wednesday, October 22, 2025 | 12pm CST

Perinatal Opioid Use Disorder Series #4

Objectives:

• Review the prevalence of perinatal opioid use
• Describe the spectrum of treatment for pregnant patients that use substances including medications, therapy, prenatal care, and Labor and Delivery planning
• Understand the roles and impact of the multidisciplinary team including healthcare providers and community-based supports

Registration

Wednesday, November 12, 2025 | 12pm CST

Perinatal Mental Health Series #4

Objectives:

• Identify risks of untreated bipolar disorder in pregnancy. 
• Describe link between postpartum psychosis and bipolar disorder discuss common treatments (e.g. lithium, valproic acid, carbamazepine, lamotrigine, class of atypical antipsychotics). 
• Describe risks to the fetus and newborn of exposure to mood stabilizers (e.g. lithium, valproic acid, carbamazepine, lamotrigine, class of atypical antipsychotics) in utero. 

Registration